Medipharm Labs Corp T.LABS

International growth.

[alleyesonme]

International growth potential is where it's at....regulatory hurdles and expenses will pay off and I think we are in for a good surprise come q3..cdn market is an afterthought for me...I have to say the writedowns really piss me off...they need to focus on the top 10 sku's and the rest just stop making already...infused sunscreens is just stupid...now with the balance sheet strong thanks to dilution the upside is compelling at these prices...looking forward to q3....trials are very significant and doctors will be happy to prescribe cbd which is very safe in comparison to all other medications..very bullish and loaded more today at .255 ,happy to hold...

[mdjbrown]

Agree 100% alleyesonme.  This one certainly isnt a sprint, but more a methodical controlled jog to the finish line With gradual increases in revenue the last 2 quarters, I expect another increase in over all sales as Medipharm products reach further corners of the world. As you mention, positive results from trials could certainly add a lot of traction. Germany politically changing their

[alleyesonme]

Bang on!...they invested heavily to get the certifications, and approvals to service the 30 or so international sales agreements...It would appear that the phase of making shipments is here..I would imagine they've learned from the inventory write downs this year the importance of narrowing the product offerings, and discontinuing products that don't sell..the McMaster University study for

[mcamm10]

This post has been removed in accordance with Community Policy